Payment overview · 2025
General Payments
$221.81
4 reported records · 4 companies
Healthcare provider profile · identity verified
Sandeep Sharma, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · ROCKVILLE, MD · NPI 1194734376
Verified facts
What the public records show
CMS Open Payments records show Sandeep Sharma, M.D. received $221.81 in general payments during 2025 across 4 reported records.
Neurocrine BioSciences, Inc. accounted for 47.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $104.98 | 47.3% | 1 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $96.90 | 43.7% | 1 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $16.86 | 7.6% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $3.07 | 1.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $221.81 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $104.98 | 1 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $96.90 | 1 | 2025 |
Source payment records
|
|||||
| Fluency Endovascular Stent Graft Normalized: fluency endovascular stent graft |
Device | Bard Peripheral Vascular, Inc. | $16.86 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $3.07 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $3.07 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1397 | 237 |
| Amlodipine Besylate | Amlodipine Besylate | 997 | 161 |
| Eliquis | Apixaban | 724 | 98 |
| Levothyroxine Sodium | Levothyroxine Sodium | 724 | 113 |
| Furosemide | Furosemide | 714 | 138 |
| Losartan Potassium | Losartan Potassium | 563 | 95 |
| Quetiapine Fumarate | Quetiapine Fumarate | 514 | 74 |
| Gabapentin | Gabapentin | 502 | 90 |
| Mirtazapine | Mirtazapine | 461 | 77 |
| Sertraline Hcl | Sertraline Hcl | 460 | 58 |
| Donepezil Hcl | Donepezil Hcl | 459 | 70 |
| Metoprolol Succinate | Metoprolol Succinate | 431 | 81 |
| Lisinopril | Lisinopril | 418 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 413 | 71 |
| Trazodone Hcl | Trazodone Hcl | 410 | 62 |
| Metoprolol Tartrate | Metoprolol Tartrate | 385 | 60 |
| Memantine Hcl | Memantine Hcl | 384 | 54 |
| Famotidine | Famotidine | 376 | 58 |
| Escitalopram Oxalate | Escitalopram Oxalate | 365 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 347 | 67 |
| Omeprazole | Omeprazole | 345 | 60 |
| Metformin Hcl | Metformin Hcl | 300 | 52 |
| Divalproex Sodium | Divalproex Sodium | 280 | 46 |
| Potassium Chloride | Potassium Chloride | 269 | 52 |
| Carvedilol | Carvedilol | 244 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 236 | 38 |
| Xarelto | Rivaroxaban | 221 | 26 |
| Levetiracetam | Levetiracetam | 211 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 210 | 32 |
| Prednisone | Prednisone | 208 | 50 |
| Latanoprost | Latanoprost | 182 | 31 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 181 | 25 |
| Hydralazine Hcl | Hydralazine Hcl | 178 | 42 |
| Lactulose | Lactulose | 144 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 138 | 24 |
| Allopurinol | Allopurinol | 137 | 20 |
| Risperidone | Risperidone | 133 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 130 | 20 |
| Jardiance | Empagliflozin | 125 | 20 |
| Finasteride | Finasteride | 122 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 116 | 52 |
| Spironolactone | Spironolactone | 112 | 19 |
| Baclofen | Baclofen | 110 | 17 |
| Tramadol Hcl | Tramadol Hcl | 106 | 38 |
| Simvastatin | Simvastatin | 101 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 100 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 96 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 94 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 91 | 11 |
| Januvia | Sitagliptin Phosphate | 85 | 12 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 84 | 38 |
| Doxycycline Hyclate | Doxycycline Hyclate | 83 | 52 |
| Procrit | Epoetin Alfa | 83 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 82 | 17 |
| Entresto | Sacubitril/Valsartan | 82 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 80 | suppressed |
| Sucralfate | Sucralfate | 77 | 14 |
| Clonazepam | Clonazepam | 76 | suppressed |
| Aripiprazole | Aripiprazole | 72 | suppressed |
| Bupropion Xl | Bupropion Hcl | 72 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 70 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 25 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 61 | 13 |
| Myrbetriq | Mirabegron | 61 | 12 |
| Humalog Kwikpen U-100 | Insulin Lispro | 60 | 14 |
| Midodrine Hcl | Midodrine Hcl | 60 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 59 | 32 |
| Ezetimibe | Ezetimibe | 58 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 57 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 56 | 15 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 55 | 13 |
| Timolol Maleate | Timolol Maleate | 55 | 13 |
| Atenolol | Atenolol | 53 | suppressed |
| Glipizide | Glipizide | 52 | suppressed |
| Pregabalin | Pregabalin | 52 | 13 |
| Primidone | Primidone | 52 | suppressed |
| Retacrit | Epoetin Alfa-Epbx | 52 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 52 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 52 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 51 | suppressed |
| Lorazepam | Lorazepam | 51 | 15 |
| Montelukast Sodium | Montelukast Sodium | 49 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 48 | suppressed |
| Tradjenta | Linagliptin | 48 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 47 | suppressed |
| Celecoxib | Celecoxib | 46 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 44 | suppressed |
| Olanzapine | Olanzapine | 44 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 42 | 14 |
| Lidocaine | Lidocaine | 42 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 40 | 24 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | suppressed |
| Lansoprazole | Lansoprazole | 40 | suppressed |
| Scopolamine | Scopolamine | 40 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 39 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 39 | suppressed |
| Glimepiride | Glimepiride | 39 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 39 | 16 |
| Ketoconazole | Ketoconazole | 39 | 16 |
| Oxcarbazepine | Oxcarbazepine | 39 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 39 | suppressed |
| Dutasteride | Dutasteride | 38 | suppressed |
| Levemir Flexpen | Insulin Detemir | 38 | suppressed |
| Alprazolam | Alprazolam | 37 | 17 |
| Clonidine Hcl | Clonidine Hcl | 37 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 37 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Colchicine | Colchicine | 36 | suppressed |
| Irbesartan | Irbesartan | 35 | suppressed |
| Torsemide | Torsemide | 35 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 34 | suppressed |
| Rexulti | Brexpiprazole | 34 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 33 | 17 |
| Ceftriaxone | Ceftriaxone Sodium | 32 | 21 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 31 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 31 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 31 | suppressed |
| Metolazone | Metolazone | 31 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Calcitriol | Calcitriol | 30 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | 11 |
| Kapspargo Sprinkle | Metoprolol Succinate | 30 | suppressed |
| Mupirocin | Mupirocin | 30 | 20 |
| Valproic Acid | Valproic Acid | 30 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 29 | suppressed |
| Loperamide | Loperamide Hcl | 29 | 17 |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 29 | 29 |
| Sevelamer Carbonate | Sevelamer Carbonate | 29 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 28 | suppressed |
| Bumetanide | Bumetanide | 27 | suppressed |
| Cephalexin | Cephalexin | 27 | 13 |
| Ibuprofen | Ibuprofen | 27 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 27 | suppressed |
| Nystatin | Nystatin | 27 | 22 |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 26 | suppressed |
| Gemtesa | Vibegron | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 26 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 25 | suppressed |
| Lacosamide | Lacosamide | 25 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 25 | suppressed |
| Amantadine | Amantadine Hcl | 24 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 24 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 24 | suppressed |
| Meloxicam | Meloxicam | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 23 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | suppressed |
| Lovastatin | Lovastatin | 23 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 23 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 14 |
| Santyl | Collagenase Clostridium Hist. | 22 | 11 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 21 | suppressed |
| Ertapenem | Ertapenem Sodium | 21 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Novolog Flexpen | Insulin Aspart | 21 | suppressed |
| Renvela | Sevelamer Carbonate | 21 | suppressed |
| Azithromycin | Azithromycin | 20 | 12 |
| Digoxin | Digoxin | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Folic Acid | Folic Acid | 19 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 19 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 19 | 17 |
| Methadone Hcl | Methadone Hcl | 19 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | suppressed |
| Ursodiol | Ursodiol | 18 | suppressed |
| Valsartan | Valsartan | 18 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Klayesta | Nystatin | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Novolog | Insulin Aspart | 17 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 16 | 14 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Letrozole | Letrozole | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | suppressed |
| Sulfasalazine | Sulfasalazine | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 14 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 13 | suppressed |
| Lamotrigine Er | Lamotrigine | 13 | suppressed |
| Mesalamine Dr | Mesalamine | 13 | suppressed |
| Multaq | Dronedarone Hcl | 13 | suppressed |
| Sodium Chloride | Sodium Chloride 0.45 % | 13 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 13 | suppressed |
| Admelog Solostar | Insulin Lispro | 12 | suppressed |
| Alogliptin | Alogliptin Benzoate | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Fluvastatin Sodium | Fluvastatin Sodium | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Leucovorin Calcium | Leucovorin Calcium | 12 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Oxtellar Xr | Oxcarbazepine | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | 11 |
| Fluconazole | Fluconazole | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Methazolamide | Methazolamide | 11 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Sotalol | Sotalol Hcl | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $221.81 · 4 records | Neurocrine BioSciences, Inc. | Fluency Endovascular Stent Graft, INGREZZA, Kerecis GraftGuide, Kerecis SurgiClose, NUPLAZID | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error